Literature DB >> 9800739

Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure.

P MacDowall1, P A Kalra, D J O'Donoghue, S Waldek, H Mamtora, K Brown.   

Abstract

BACKGROUND: Renovasular disease commonly affects elderly people. Elderly patients with heart failure are routinely treated with angiotensin-converting-enzyme (ACE) inhibitors, which may increase risk of renal dysfunction. We investigated the frequency of renovascular disease among elderly people with heart failure.
METHODS: From the local population of Salford, UK, we recruited 86 patients with heart failure with a mean age of 77.5 (SD 5.6) years, who were admitted as acute emergencies or who attended general medical clinics. We selected patients by intention to treat with ACE inhibitors. We used captopril renography to screen for renovascular disease. All patients with abnormal renograms underwent magnetic-resonance angiography of the renal arteries as well as 40% of patients with normal renograms as negative controls.
FINDINGS: Magnetic-resonance angiography showed severe renovascular disease (>50% renal-artery stenosis or occlusion) in 29 (34%) patients. Captopril renography had an estimated sensitivity of 78.8% (95% CI 72.7-97.8) and specificity of 94.3% (67.6-97.3) for detection of renovascular disease. The estimated positive predictive value of captopril renography was 89.7% and the negative predictive value was 87.5%. Patients with renovascular disease had worse renal function (mean creatinine 201 [SD 56] vs 136 [40] pmol/L, p<0.001), were older (mean age 80.7 [5.6] vs 76.8 [5.3] years, p<0.01), and were more likely than patients without renovascular disease to have peripheral arterial disease.
INTERPRETATION: Some elderly patients with occult renovascular disease on ACE inhibitors will be at risk of developing uraemia. Renal function should be closely monitored to detect any deterioration early.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9800739     DOI: 10.1016/s0140-6736(97)11060-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

Review 1.  Renal artery stenosis as a cause of renal impairment: implications for treatment of hypertension and congestive heart failure.

Authors:  J E Scoble
Journal:  J R Soc Med       Date:  1999-10       Impact factor: 5.344

2.  Bilateral renovascular disease causing cardiorenal failure.

Authors:  Alison Brammah; Sue Robertson; Graeme Tait; Chris Isles
Journal:  BMJ       Date:  2003-03-01

3.  [Metformin-associated lactic acidosis with acute renal failure in type 2 diabetes mellitus].

Authors:  Heinrich Lothholz
Journal:  Med Klin (Munich)       Date:  2002-07-15

Review 4.  Atherosclerotic disease of the abdominal aorta and its branches: prognostic implications in patients with heart failure.

Authors:  Christos V Bourantas; Huan P Loh; Nasser Sherwi; Ann C Tweddel; Ramesh de Silva; Elena I Lukaschuk; Antony Nicholson; Alan S Rigby; Simon D Thackray; Duncan F Ettles; Nikolay P Nikitin; Andrew L Clark; John G F Cleland
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 5.  Atherosclerotic renal artery stenosis, ACE inhibitors, and avoiding cardiovascular death.

Authors:  John Main
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

Review 6.  Acute renal failure.

Authors:  Rachel Hilton
Journal:  BMJ       Date:  2006-10-14

Review 7.  Renal Artery Stenosis and Congestive Heart Failure: What Do We Really Know?

Authors:  Rajesh Gupta; Mubbasher Syed; Nikita Ashcherkin; Katherine Chen; Palavi P Vaidya; Christopher J Cooper
Journal:  Curr Cardiol Rep       Date:  2019-06-24       Impact factor: 2.931

Review 8.  [Renal artery stenosis. Pathophysiology--diagnosis--therapy].

Authors:  Heinrich Wieneke; Thomas Friedrich Michael Konorza; Holger Eggebrecht; Christoph Kurt Naber; Sebastian Philipp; Thomas Philipp; Andreas Kribben; Raimund Erbel
Journal:  Med Klin (Munich)       Date:  2009-05-16

Review 9.  Atherosclerotic renal artery stenosis: surgery, percutaneous transluminal angioplasty, or medical therapy?

Authors:  P F Plouin; B Guéry; A La Batide Alanore
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

10.  Taking precautions with angiotensin converting enzyme inhibitors. Angiotensin converting enzyme inhibitors are not proved to cause loss of renal mass.

Authors:  J D Louden; J Main
Journal:  BMJ       Date:  1999-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.